Investigation of the mechanism of Pemetrexed sensitivity in Docetaxel-resistant lung cancer cells
碩士 === 中山醫學大學 === 醫學研究所 === 103 === Chemotherapy is the common treatment for lung cancer patients. The development of drug resistance is the most important cause of treatment failure. When cancer resistant to chemotheraputic drugs, it is commonly developed cross-resistance to other anti-cancer drugs...
Main Authors: | Zih-Yao Lin, 林子堯 |
---|---|
Other Authors: | 許國堂 |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/30996058529106438952 |
Similar Items
-
Study the Alimta sensitivity in Docetaxel resistant lung cancer cell
by: Yu-Chen, et al.
Published: (2011) -
An investigation of the molecular mechanisms of docetaxel resistance in breast cancer cells
by: Sangrithi-Wallace, Jay N.
Published: (2009) -
Investigation of Pemetrexed(Alimta)cytotoxicity with non-small cell lung cancer cell lines
by: Chia-Chia, et al.
Published: (2007) -
PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
by: A. U. Kulikov
Published: (2015-03-01) -
Association of thymidylate synthase gene 3'-untranslated region polymorphism with sensitivity of non-small cell lung cancer to pemetrexed treatment: TS gene polymorphism and pemetrexed sensitivity in NSCLC
by: Wang Xia, et al.
Published: (2013-01-01)